Nanalysis Scientific (CVE:NSCI) Trading Down 19.6% – Time to Sell?

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s share price was down 19.6% during trading on Friday . The company traded as low as C$0.18 and last traded at C$0.19. Approximately 802,183 shares were traded during trading, an increase of 866% from the average daily volume of 83,002 shares. The stock had previously closed at C$0.23.

Nanalysis Scientific Price Performance

The company has a quick ratio of 1.11, a current ratio of 1.42 and a debt-to-equity ratio of 71.72. The firm has a market cap of C$20.95 million, a P/E ratio of -1.68 and a beta of -0.75. The business has a fifty day moving average of C$0.24 and a 200 day moving average of C$0.27.

About Nanalysis Scientific

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

See Also

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.